Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127276663 | 12727666 | 3 | F | 1983 | 20160921 | 20160909 | 20160928 | EXP | US-PFIZER INC-2016387041 | PFIZER | 66.00 | YR | F | Y | 77.11000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127276663 | 12727666 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, DAILY | 20998 | 200 | MG | CAPSULE, HARD | |||||||
| 127276663 | 12727666 | 2 | SS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY (ONCE DAILY) | C140334 | 20998 | 200 | MG | CAPSULE, HARD | QD | |||||
| 127276663 | 12727666 | 3 | SS | CELEBREX | CELECOXIB | 1 | 20998 | CAPSULE, HARD | |||||||||||
| 127276663 | 12727666 | 4 | SS | CELEBREX | CELECOXIB | 1 | 20998 | CAPSULE, HARD | |||||||||||
| 127276663 | 12727666 | 5 | C | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | 0.5 MG, DAILY | 0 | .5 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 6 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 40 MG, DAILY | 0 | 40 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 7 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | 100 MG, UNK (1 AT ONSET; MAY REPEAT IN 2 HOURS) | 0 | 100 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 8 | C | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 0 | 100 | MG | CAPSULE | TID | ||||||
| 127276663 | 12727666 | 9 | C | LYRICA | PREGABALIN | 1 | 0 | CAPSULE | |||||||||||
| 127276663 | 12727666 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, DAILY | 0 | 40 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 50000 IU, WEEKLY (1 PER WEEK (D2)) | 0 | 50000 | IU | TABLET | /wk | |||||||
| 127276663 | 12727666 | 12 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 15 MG, 1X/DAY (1 TABLET AT BEDTIME) | 0 | 15 | MG | TABLET | QD | |||||||
| 127276663 | 12727666 | 13 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | TABLET | |||||||||||
| 127276663 | 12727666 | 14 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 50 MG, 1X/DAY (1 TABLET AT BEDTIME) | 0 | 50 | MG | TABLET | QD | |||||||
| 127276663 | 12727666 | 15 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 127276663 | 12727666 | 16 | C | D-AMPHETAMINE SALTS | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 10 MG, DAILY | 0 | 10 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 17 | C | D-AMPHETAMINE SALTS | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 | TABLET | |||||||||||
| 127276663 | 12727666 | 18 | C | TIZANIDINE. | TIZANIDINE | 1 | UNK, 2X/DAY (4 MG, 1/2 TO 1 PILL TWICE DAILY)) | 0 | BID | ||||||||||
| 127276663 | 12727666 | 19 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | 10 MG, AS NEEDED (EVERY 6 HOURS AS NEEDED) | 0 | 10 | MG | |||||||||
| 127276663 | 12727666 | 20 | C | ESTRADIOL. | ESTRADIOL | 1 | .5 MG, 2X/DAY (1 IN AM; 1 AT PM) | 0 | .5 | MG | BID | ||||||||
| 127276663 | 12727666 | 21 | C | MEDROXYPROGESTERONE | MEDROXYPROGESTERONE | 1 | 2.5 MG, DAILY | 0 | 2.5 | MG | |||||||||
| 127276663 | 12727666 | 22 | C | COLESTIPOL | COLESTIPOL | 1 | 1 G, AS NEEDED | 0 | 1 | G | |||||||||
| 127276663 | 12727666 | 23 | C | LISINOPRIL. | LISINOPRIL | 1 | 20 MG, DAILY | 0 | 20 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 24 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK (OXYCODONE: 10MG- ACETAMINOPHEN: 325MG) (EVERY 6-8 HRS) | 0 | TABLET | ||||||||||
| 127276663 | 12727666 | 25 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK [OXYCODONE: 7.5MG]/[ACETAMINOPHEN: 325MG] (EVERY 6-8 HRS) | 0 | TABLET | ||||||||||
| 127276663 | 12727666 | 26 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 127276663 | 12727666 | 27 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 28 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 29 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 30 | C | DIAZEPAM. | DIAZEPAM | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 31 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 32 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | UNK | 0 | |||||||||||
| 127276663 | 12727666 | 33 | C | LYRICA | PREGABALIN | 1 | 300 MG, DAILY | 0 | 300 | MG | TABLET | ||||||||
| 127276663 | 12727666 | 34 | C | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | 0 | 100 | MG | TABLET | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127276663 | 12727666 | 1 | Osteoarthritis |
| 127276663 | 12727666 | 2 | Multiple sclerosis |
| 127276663 | 12727666 | 3 | Osteopenia |
| 127276663 | 12727666 | 4 | Arthritis |
| 127276663 | 12727666 | 5 | Multiple sclerosis relapse |
| 127276663 | 12727666 | 6 | Multiple sclerosis |
| 127276663 | 12727666 | 7 | Migraine |
| 127276663 | 12727666 | 8 | Multiple sclerosis |
| 127276663 | 12727666 | 9 | Neuralgia |
| 127276663 | 12727666 | 10 | Multiple sclerosis |
| 127276663 | 12727666 | 11 | Multiple sclerosis |
| 127276663 | 12727666 | 12 | Multiple sclerosis |
| 127276663 | 12727666 | 13 | Sleep disorder |
| 127276663 | 12727666 | 14 | Multiple sclerosis |
| 127276663 | 12727666 | 15 | Sleep disorder |
| 127276663 | 12727666 | 16 | Multiple sclerosis |
| 127276663 | 12727666 | 17 | Asthenia |
| 127276663 | 12727666 | 18 | Muscle relaxant therapy |
| 127276663 | 12727666 | 19 | Irritable bowel syndrome |
| 127276663 | 12727666 | 20 | Hormone therapy |
| 127276663 | 12727666 | 22 | Irritable bowel syndrome |
| 127276663 | 12727666 | 23 | Hypertension |
| 127276663 | 12727666 | 24 | Pain |
| 127276663 | 12727666 | 33 | Multiple sclerosis |
| 127276663 | 12727666 | 34 | Neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127276663 | 12727666 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127276663 | 12727666 | Drug ineffective for unapproved indication | |
| 127276663 | 12727666 | Myalgia | |
| 127276663 | 12727666 | Neuralgia | |
| 127276663 | 12727666 | Pain | |
| 127276663 | 12727666 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127276663 | 12727666 | 2 | 2000 | 0 | ||
| 127276663 | 12727666 | 5 | 2012 | 0 | ||
| 127276663 | 12727666 | 6 | 2005 | 0 | ||
| 127276663 | 12727666 | 7 | 2005 | 0 | ||
| 127276663 | 12727666 | 10 | 2007 | 0 | ||
| 127276663 | 12727666 | 11 | 2005 | 0 | ||
| 127276663 | 12727666 | 12 | 2013 | 0 | ||
| 127276663 | 12727666 | 14 | 2013 | 0 | ||
| 127276663 | 12727666 | 16 | 2005 | 0 | ||
| 127276663 | 12727666 | 18 | 2016 | 0 | ||
| 127276663 | 12727666 | 19 | 2010 | 0 | ||
| 127276663 | 12727666 | 20 | 2010 | 0 | ||
| 127276663 | 12727666 | 21 | 2010 | 0 | ||
| 127276663 | 12727666 | 22 | 2012 | 0 | ||
| 127276663 | 12727666 | 23 | 2010 | 0 | ||
| 127276663 | 12727666 | 26 | 2005 | 0 | ||
| 127276663 | 12727666 | 28 | 2010 | 0 |